SUN PHARMACEUTICAL INDUSTRIESSUN PHARMACEUTICAL INDUSTRIESSUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES

No trades
See on Supercharts
Market capitalization
‪3.64 T‬INR
‪84.74 B‬INR
‪438.86 B‬INR
‪1.02 B‬
Beta (1Y)
0.58

About SUN PHARMACEUTICAL INDUSTRIES

CEO
Dilip Shantilal Shanghvi
Headquarters
Mumbai
Employees (FY)
‪24.77 K‬
Founded
1983
ISIN
INE044A01036
FIGI
BBG000BV5GT6
Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. It offers tablets, capsules, injectable, inhalers, ointments, creams, and liquids. The company was founded by Dilip Shantilal Shanghvi in 1983 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where SUNPHARMA is featured.

Frequently Asked Questions

The current price of SUNPHARMA is 1522.55 INR — it has increased by 0.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SUN PHARMACEUTICAL INDUSTRIES stocks are traded under the ticker SUNPHARMA.
SUN PHARMACEUTICAL INDUSTRIES is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
SUNPHARMA stock is 1.78% volatile and has beta coefficient of 0.58. Check out the list of the most volatile stocks — is SUN PHARMACEUTICAL INDUSTRIES there?
One year price forecast for SUN PHARMACEUTICAL INDUSTRIES has a max estimate of 1827.00 INR and a min estimate of 1200.00 INR.
SUNPHARMA earnings for the last quarter are 9.90 INR per share, whereas the estimation was 8.98 INR resulting in a 10.24% surprise. The estimated earnings for the next quarter are 9.95 INR per share. See more details about SUN PHARMACEUTICAL INDUSTRIES earnings.
SUN PHARMACEUTICAL INDUSTRIES revenue for the last quarter amounts to ‪121.92 B‬ INR despite the estimated figure of ‪120.69 B‬ INR. In the next quarter revenue is expected to reach ‪122.79 B‬ INR.
Yes, you can track SUN PHARMACEUTICAL INDUSTRIES financials in yearly and quarterly reports right on TradingView.
SUNPHARMA stock has fallen by 4.83% compared to the previous week, the month change is a 2.13% fall, over the last year SUN PHARMACEUTICAL INDUSTRIES has showed a 51.96% increase.
SUNPHARMA net income for the last quarter is ‪25.24 B‬ INR, while the quarter before that showed ‪23.76 B‬ INR of net income which accounts for 6.24% change. Track more SUN PHARMACEUTICAL INDUSTRIES financial stats to get the full picture.
Today SUN PHARMACEUTICAL INDUSTRIES has the market capitalization of ‪3.64 T‬, it has decreased by 1.38% over the last week.
SUN PHARMACEUTICAL INDUSTRIES dividend yield was 1.17% in 2022, and payout ratio reached 32.56%. The year before the numbers were 1.09% and 73.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SUNPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMACEUTICAL INDUSTRIES stock right from TradingView charts — choose your broker and connect to your account.
SUNPHARMA reached its all-time high on Apr 5, 2024 with the price of 1638.70 INR, and its all-time low was 26.00 INR and was reached on Oct 30, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪24.77 K‬ employees. See our rating of the largest employees — is SUN PHARMACEUTICAL INDUSTRIES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUN PHARMACEUTICAL INDUSTRIES technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUN PHARMACEUTICAL INDUSTRIES stock shows the buy signal. See more of SUN PHARMACEUTICAL INDUSTRIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SUN PHARMACEUTICAL INDUSTRIES future price: according to them, SUNPHARMA price has a max estimate of 1827.00 INR and a min estimate of 1200.00 INR. Read a more detailed SUN PHARMACEUTICAL INDUSTRIES forecast: see what analysts think of SUN PHARMACEUTICAL INDUSTRIES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMACEUTICAL INDUSTRIES EBITDA is ‪127.25 B‬ INR, and current EBITDA margin is 26.52%. See more stats in SUN PHARMACEUTICAL INDUSTRIES financial statements.